{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T23:09:42Z","timestamp":1790636982942,"version":"4.1.0"},"reference-count":51,"publisher":"Oxford University Press (OUP)","issue":"10","license":[{"start":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T00:00:00Z","timestamp":1746316800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Regions of Southern Denmark Research Funds"},{"DOI":"10.13039\/100008363","name":"Danish Cancer Society","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008363","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009708","name":"Novo Nordisk Foundation","doi-asserted-by":"publisher","award":["NNF19OC0058427"],"award-info":[{"award-number":["NNF19OC0058427"]}],"id":[{"id":"10.13039\/501100009708","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,10,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Glioblastoma undergoes a complex and dynamic evolution involving genetic and epigenetic changes. Understanding the mechanisms underlying this evolution is vital for the development of efficient therapeutic strategies. Although treatment resistance is associated with intratumoral heterogeneity in glioblastoma, it remains uncertain whether hypometabolic and hypermetabolic lesions observed through clinical positron emission tomography (PET) imaging are influenced by spatial intratumoral genomic evolution.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>In this study, we precisely isolated autologous hypometabolic and hypermetabolic lesions from glioblastoma using advanced neurosurgical and brain tumor imaging technologies, followed by comprehensive whole-genome, exome, transcriptome, and imaging analyses.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Our findings unveil that hypermetabolic lesions, originating from hypometabolic lesions, exhibit strategic focal amplifications and deletions, and heightened APOBEC3 activity. Furthermore, we identify dipeptidase 1 as a novel vascular endothelial tip marker for hypermetabolic lesions in glioblastoma, facilitating angiogenesis and tumor metabolism by regulating transporter activities.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Hypermetabolic lesions are associated with a higher frequency of genomic abnormalities and dipeptidase 1 emerges as a novel diagnostic and prognostic vascular marker for hypermetabolic lesions. This study underscores a spatial genomic evolution with diagnostic implications and elucidates challenges and opportunities crucial for the development of novel therapeutic strategies.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/neuonc\/noaf071","type":"journal-article","created":{"date-parts":[[2025,3,19]],"date-time":"2025-03-19T17:58:05Z","timestamp":1742407085000},"page":"2547-2563","source":"Crossref","is-referenced-by-count":4,"title":["Multiomic profiling of glioblastoma metabolic lesions reveals complex intratumoral genomic evolution and dipeptidase-1-driven vascular proliferation"],"prefix":"10.1093","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7474-5433","authenticated-orcid":false,"given":"Atul","family":"Anand","sequence":"first","affiliation":[{"name":"Department of Pathology, The Bartholin Institute, Rigshospitalet, Copenhagen University Hospital , Copenhagen ,","place":["Denmark"]},{"name":"Department of Clinical Medicine and Biotech Research and Innovation Center (BRIC), University of Copenhagen , Copenhagen ,","place":["Denmark"]},{"name":"Department of Clinical Research, University of Southern Denmark , Odense ,","place":["Denmark"]},{"name":"Department of Pathology, Odense University Hospital , Odense ,","place":["Denmark"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeanette Krogh","family":"Petersen","sequence":"additional","affiliation":[{"name":"Department of Pathology, Odense University Hospital , Odense ,","place":["Denmark"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lars van Brakel","family":"Andersen","sequence":"additional","affiliation":[{"name":"Clinical Genome Center, Department of Clinical Research, University of Southern Denmark , Odense ,","place":["Denmark"]},{"name":"Department of Clinical Genetics, Odense University Hospital , Odense ,","place":["Denmark"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Burton","sequence":"additional","affiliation":[{"name":"Clinical Genome Center, Department of Clinical Research, University of Southern Denmark , Odense ,","place":["Denmark"]},{"name":"Department of Clinical Genetics, Odense University Hospital , Odense ,","place":["Denmark"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5466-0755","authenticated-orcid":false,"given":"Clara Rosa Levina","family":"Oudenaarden","sequence":"additional","affiliation":[{"name":"Department of Pathology, The Bartholin Institute, Rigshospitalet, Copenhagen University Hospital , Copenhagen ,","place":["Denmark"]},{"name":"Department of Clinical Medicine and Biotech Research and Innovation Center (BRIC), University of Copenhagen , Copenhagen ,","place":["Denmark"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin Jakob","family":"Larsen","sequence":"additional","affiliation":[{"name":"Clinical Genome Center, Department of Clinical Research, University of Southern Denmark , Odense ,","place":["Denmark"]},{"name":"Department of Clinical Genetics, Odense University Hospital , Odense ,","place":["Denmark"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip Ahle","family":"Erichsen","sequence":"additional","affiliation":[{"name":"Department of Pathology, The Bartholin Institute, Rigshospitalet, Copenhagen University Hospital , Copenhagen ,","place":["Denmark"]},{"name":"Department of Clinical Medicine and Biotech Research and Innovation Center (BRIC), University of Copenhagen , Copenhagen ,","place":["Denmark"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian Bonde","family":"Pedersen","sequence":"additional","affiliation":[{"name":"BRIDGE, Brain Research - Inter Disciplinary Guided Excellence, Odense University Hospital and University of Southern Denmark , Odense ,","place":["Denmark"]},{"name":"Department of Neurosurgery, Odense University Hospital , Odense ,","place":["Denmark"]},{"name":"Department of Clinical Research, University of Southern Denmark , Odense ,","place":["Denmark"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frantz Rom","family":"Poulsen","sequence":"additional","affiliation":[{"name":"BRIDGE, Brain Research - Inter Disciplinary Guided Excellence, Odense University Hospital and University of Southern Denmark , Odense ,","place":["Denmark"]},{"name":"Department of Neurosurgery, Odense University Hospital , Odense ,","place":["Denmark"]},{"name":"Department of Clinical Research, University of Southern Denmark , Odense ,","place":["Denmark"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Grupe","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine, Odense University Hospital , Odense ,","place":["Denmark"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Torben A","family":"Kruse","sequence":"additional","affiliation":[{"name":"Clinical Genome Center, Department of Clinical Research, University of Southern Denmark , Odense ,","place":["Denmark"]},{"name":"Department of Clinical Genetics, Odense University Hospital , Odense ,","place":["Denmark"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mads","family":"Thomassen","sequence":"additional","affiliation":[{"name":"Clinical Genome Center, Department of Clinical Research, University of Southern Denmark , Odense ,","place":["Denmark"]},{"name":"Department of Clinical Genetics, Odense University Hospital , Odense ,","place":["Denmark"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6352-0826","authenticated-orcid":false,"given":"Bjarne Winther","family":"Kristensen","sequence":"additional","affiliation":[{"name":"Department of Pathology, The Bartholin Institute, Rigshospitalet, Copenhagen University Hospital , Copenhagen ,","place":["Denmark"]},{"name":"Department of Clinical Medicine and Biotech Research and Innovation Center (BRIC), University of Copenhagen , Copenhagen ,","place":["Denmark"]},{"name":"Department of Clinical Research, University of Southern Denmark , Odense ,","place":["Denmark"]},{"name":"Department of Pathology, Odense University Hospital , Odense ,","place":["Denmark"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2025,5,4]]},"reference":[{"key":"2026012603472386900_CIT0001","doi-asserted-by":"crossref","first-page":"v1","DOI":"10.1093\/neuonc\/noac202","article-title":"CBTRUS statistical report: Primary brain and other central nervous system tumors diagnosed in the United States in 2015-2019","volume":"24","author":"Ostrom","year":"2022","journal-title":"Neuro Oncol."},{"issue":"8","key":"2026012603472386900_CIT0002","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1093\/neuonc\/noab106","article-title":"The 2021 WHO classification of tumors of the central nervous system: A summary","volume":"23","author":"Louis","year":"2021","journal-title":"Neuro Oncol."},{"issue":"10","key":"2026012603472386900_CIT0003","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1056\/NEJMoa043330","article-title":"Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma","volume":"352","author":"Stupp","year":"2005","journal-title":"N Engl J Med."},{"issue":"4","key":"2026012603472386900_CIT0004","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1016\/j.cell.2019.06.024","article-title":"An integrative model of cellular states, plasticity, and genetics for glioblastoma","volume":"178","author":"Neftel","year":"2019","journal-title":"Cell."},{"issue":"8","key":"2026012603472386900_CIT0005","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1038\/s43018-022-00403-z","article-title":"Structural variants shape driver combinations and outcomes in pediatric high-grade glioma","volume":"3","author":"Dubois","year":"2022","journal-title":"Nat Cancer."},{"issue":"7","key":"2026012603472386900_CIT0006","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1038\/ng.3590","article-title":"Clonal evolution of glioblastoma under therapy","volume":"48","author":"Wang","year":"2016","journal-title":"Nat Genet."},{"issue":"12","key":"2026012603472386900_CIT0007","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1038\/s43018-022-00475-x","article-title":"A single-cell atlas of glioblastoma evolution under therapy reveals cell-intrinsic and cell-extrinsic therapeutic targets","volume":"3","author":"Wang","year":"2022","journal-title":"Nat Cancer."},{"issue":"2","key":"2026012603472386900_CIT0008","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1093\/neuonc\/noac211","article-title":"Characterizing the biology of primary brain tumors and their microenvironment via single-cell profiling methods","volume":"25","author":"Gonzalez Castro","year":"2023","journal-title":"Neuro Oncol."},{"issue":"1","key":"2026012603472386900_CIT0009","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.ccr.2009.12.020","article-title":"Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1","volume":"17","author":"Verhaak","year":"2010","journal-title":"Cancer Cell."},{"issue":"1","key":"2026012603472386900_CIT0010","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1158\/2159-8290.CD-21-0291","article-title":"Characterization of the genomic and immunologic diversity of malignant brain tumors through multisector analysis","volume":"12","author":"Schaettler","year":"2022","journal-title":"Cancer Discov."},{"issue":"1","key":"2026012603472386900_CIT0011","doi-asserted-by":"crossref","first-page":"6066","DOI":"10.1038\/s41467-023-41559-1","article-title":"Integrated molecular and multiparametric MRI mapping of high-grade glioma identifies regional biologic signatures","volume":"14","author":"Hu","year":"2023","journal-title":"Nat Commun."},{"issue":"1","key":"2026012603472386900_CIT0012","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1038\/s41597-022-01560-7","article-title":"The University of Pennsylvania glioblastoma (UPenn-GBM) cohort: Advanced MRI, clinical, genomics, & radiomics","volume":"9","author":"Bakas","year":"2022","journal-title":"Sci Data."},{"issue":"11","key":"2026012603472386900_CIT0013","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1093\/neuonc\/noac131","article-title":"Investigational PET tracers in neuro-oncology-What\u2019s on the horizon? A report of the PET\/RANO group","volume":"24","author":"Galldiks","year":"2022","journal-title":"Neuro Oncol."},{"issue":"7","key":"2026012603472386900_CIT0014","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1093\/neuonc\/noae049","article-title":"Challenges, limitations and pitfalls of PET and advanced mri in patients with brain tumors - a report of the PET\/RANO group","volume":"26","author":"Galldiks","year":"2024","journal-title":"Neuro Oncol."},{"issue":"6","key":"2026012603472386900_CIT0015","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1002\/mrm.25560","article-title":"Contrast enhancement by combining T1- and T2-weighted structural brain MR Images","volume":"74","author":"Misaki","year":"2015","journal-title":"Magn Reson Med."},{"issue":"Jul","key":"2026012603472386900_CIT0016","doi-asserted-by":"crossref","first-page":"107610","DOI":"10.1016\/j.intimp.2021.107610","article-title":"Comprehensive exploration of tumor mutational burden and immune infiltration in diffuse glioma","volume":"96","author":"Kang","year":"2021","journal-title":"Int Immunopharmacol."},{"issue":"12","key":"2026012603472386900_CIT0017","doi-asserted-by":"crossref","first-page":"1808","DOI":"10.1158\/2159-8290.CD-20-0522","article-title":"Tumor mutational burden as a predictive biomarker in solid tumors","volume":"10","author":"Sha","year":"2020","journal-title":"Cancer Discov."},{"issue":"1","key":"2026012603472386900_CIT0018","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1186\/s13059-020-02035-x","article-title":"Whole-genome sequencing of glioblastoma reveals enrichment of non-coding constraint mutations in known and novel genes","volume":"21","author":"Sakthikumar","year":"2020","journal-title":"Genome Biol."},{"issue":"4","key":"2026012603472386900_CIT0019","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1016\/j.ccell.2019.02.007","article-title":"Evolutionary Trajectories of IDH(WT) glioblastomas reveal a common path of early tumorigenesis instigated years ahead of initial diagnosis","volume":"35","author":"Korber","year":"2019","journal-title":"Cancer Cell."},{"issue":"4","key":"2026012603472386900_CIT0020","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1093\/neuonc\/nox232","article-title":"Biological and therapeutic implications of multisector sequencing in newly diagnosed glioblastoma","volume":"20","author":"Mahlokozera","year":"2018","journal-title":"Neuro Oncol."},{"key":"2026012603472386900_CIT0021","doi-asserted-by":"crossref","DOI":"10.15586\/codon.glioblastoma.2017.ch1","article-title":"Glioblastoma genomics:A very complicated story","volume-title":"Glioblastoma","author":"Lombardi","year":"2017"},{"issue":"11","key":"2026012603472386900_CIT0022","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1101\/gr.180281.114","article-title":"TITAN: Inference of copy number architectures in clonal cell populations from tumor whole-genome sequence data","volume":"24","author":"Ha","year":"2014","journal-title":"Genome Res."},{"issue":"7","key":"2026012603472386900_CIT0023","doi-asserted-by":"crossref","first-page":"1760","DOI":"10.1038\/s41375-020-0723-2","article-title":"Clinical significance of TP53, BIRC3, ATM and MAPK-ERK genes in chronic lymphocytic leukaemia: Data from the randomised UK LRF CLL4 trial","volume":"34","author":"Blakemore","year":"2020","journal-title":"Leukemia."},{"issue":"6350","key":"2026012603472386900_CIT0024","article-title":"HNF4A defines tissue-specific circadian rhythms by beaconing BMAL1::CLOCK chromatin binding and shaping the rhythmic chromatin landscape","volume":"12","author":"Qu","year":"2021","journal-title":"Nat Commun."},{"issue":"3","key":"2026012603472386900_CIT0025","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1215\/15228517-2007-009","article-title":"Characterization of the amplicon on chromosomal segment 4q12 in glioblastoma multiforme","volume":"9","author":"Holtkamp","year":"2007","journal-title":"Neuro Oncol."},{"issue":"1","key":"2026012603472386900_CIT0026","doi-asserted-by":"crossref","first-page":"6704","DOI":"10.1038\/s41467-021-26871-y","article-title":"Genetic fusions favor tumorigenesis through degron loss in oncogenes","volume":"12","author":"Liu","year":"2021","journal-title":"Nat Commun."},{"issue":"6","key":"2026012603472386900_CIT0027","doi-asserted-by":"crossref","first-page":"eabm2382","DOI":"10.1126\/sciadv.abm2382","article-title":"A functional genomic approach to actionable gene fusions for precision oncology","volume":"8","author":"Li","year":"2022","journal-title":"Sci Adv."},{"issue":"7903","key":"2026012603472386900_CIT0028","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1038\/s41586-021-04369-3","article-title":"A human brain vascular atlas reveals diverse mediators of Alzheimer\u2019s risk","volume":"603","author":"Yang","year":"2022","journal-title":"Nature."},{"issue":"12","key":"2026012603472386900_CIT0029","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1186\/s13059-014-0530-z","article-title":"Deep sequencing of multiple regions of glial tumors reveals spatial heterogeneity for mutations in clinically relevant genes","volume":"15","author":"Kumar","year":"2014","journal-title":"Genome Biol."},{"issue":"4","key":"2026012603472386900_CIT0030","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1093\/neuonc\/now231","article-title":"Comprehensive molecular characterization of multifocal glioblastoma proves its monoclonal origin and reveals novel insights into clonal evolution and heterogeneity of glioblastomas","volume":"19","author":"Abou-El-Ardat","year":"2017","journal-title":"Neuro Oncol."},{"issue":"4","key":"2026012603472386900_CIT0031","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1038\/ng.3806","article-title":"Spatiotemporal genomic architecture informs precision oncology in glioblastoma","volume":"49","author":"Lee","year":"2017","journal-title":"Nat Genet."},{"issue":"8","key":"2026012603472386900_CIT0032","doi-asserted-by":"crossref","first-page":"100165","DOI":"10.1016\/j.xgen.2022.100165","article-title":"Spatial intra-tumor heterogeneity is associated with survival of lung adenocarcinoma patients","volume":"2","author":"Wu","year":"2022","journal-title":"Cell Genom."},{"issue":"737","key":"2026012603472386900_CIT0033","article-title":"Divergent mutational processes distinguish hypoxic and normoxic tumours","volume":"11","author":"Bhandari","year":"2020","journal-title":"Nat Commun."},{"issue":"3","key":"2026012603472386900_CIT0034","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1002\/2211-5463.12384","article-title":"Suboptimal extracellular pH values alter DNA damage response to induced double-strand breaks","volume":"8","author":"Massonneau","year":"2018","journal-title":"FEBS Open Bio."},{"issue":"9","key":"2026012603472386900_CIT0035","first-page":"1184","article-title":"Metabolic characterization of human IDH mutant and wild type gliomas using simultaneous pH- and oxygen-sensitive molecular MRI","volume":"21","author":"Yao","year":"2019","journal-title":"Neuro Oncol."},{"issue":"2","key":"2026012603472386900_CIT0036","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1038\/s41588-022-01296-5","article-title":"APOBEC mutagenesis is a common process in normal human small intestine","volume":"55","author":"Wang","year":"2023","journal-title":"Nat Genet."},{"issue":"10","key":"2026012603472386900_CIT0037","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1038\/s41588-023-01504-w","article-title":"APOBEC3B regulates R-loops and promotes transcription-associated mutagenesis in cancer","volume":"55","author":"McCann","year":"2023","journal-title":"Nat Genet."},{"issue":"1","key":"2026012603472386900_CIT0038","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1038\/s41588-023-01592-8","article-title":"The role of APOBEC3B in lung tumor evolution and targeted cancer therapy resistance","volume":"56","author":"Caswell","year":"2024","journal-title":"Nat Genet."},{"issue":"1","key":"2026012603472386900_CIT0039","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1093\/neuonc\/nou318","article-title":"TERT promoter mutation designates biologically aggressive primary glioblastoma","volume":"17","author":"Huse","year":"2015","journal-title":"Neuro Oncol."},{"issue":"5","key":"2026012603472386900_CIT0040","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1007\/s00401-018-1842-y","article-title":"Reconstructing the molecular life history of gliomas","volume":"135","author":"Barthel","year":"2018","journal-title":"Acta Neuropathol."},{"issue":"1","key":"2026012603472386900_CIT0041","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1038\/s41467-022-35727-y","article-title":"Germline TP53 mutations undergo copy number gain years prior to tumor diagnosis","volume":"14","author":"Light","year":"2023","journal-title":"Nat Commun."},{"issue":"1","key":"2026012603472386900_CIT0042","doi-asserted-by":"crossref","first-page":"5430","DOI":"10.1038\/s41467-022-33099-x","article-title":"Conserved features of TERT promoter duplications reveal an activation mechanism that mimics hotspot mutations in cancer","volume":"13","author":"Barger","year":"2022","journal-title":"Nat Commun."},{"issue":"5","key":"2026012603472386900_CIT0043","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1007\/s00401-018-1913-0","article-title":"cIMPACT-NOW update 3: Recommended diagnostic criteria for \u201cDiffuse astrocytic glioma, IDH-wildtype, with molecular features of glioblastoma, WHO grade IV.\u201d","volume":"136","author":"Brat","year":"2018","journal-title":"Acta Neuropathol."},{"issue":"1","key":"2026012603472386900_CIT0044","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1038\/s41568-019-0226-5","article-title":"Altered cellular metabolism in gliomas - an emerging landscape of actionable co-dependency targets","volume":"20","author":"Bi","year":"2020","journal-title":"Nat Rev Cancer."},{"issue":"12","key":"2026012603472386900_CIT0045","doi-asserted-by":"crossref","first-page":"2136","DOI":"10.1093\/neuonc\/noad136","article-title":"A closer look at the role of iron in glioblastoma","volume":"25","author":"Shenoy","year":"2023","journal-title":"Neuro Oncol."},{"issue":"4","key":"2026012603472386900_CIT0046","doi-asserted-by":"crossref","first-page":"992","DOI":"10.3390\/cells9040992","article-title":"Hypoxia-driven immune escape in the tumor microenvironment","volume":"9","author":"Vito","year":"2020","journal-title":"Cells."},{"issue":"12","key":"2026012603472386900_CIT0047","doi-asserted-by":"crossref","first-page":"2820","DOI":"10.1158\/2159-8290.CD-22-0196","article-title":"Natural coevolution of tumor and immunoenvironment in glioblastoma","volume":"12","author":"Wu","year":"2022","journal-title":"Cancer Discov."},{"issue":"5","key":"2026012603472386900_CIT0048","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1093\/neuonc\/noac245","article-title":"ARL13B promotes angiogenesis and glioma growth by activating VEGFA-VEGFR2 signaling","volume":"25","author":"Chen","year":"2023","journal-title":"Neuro Oncol."},{"issue":"4","key":"2026012603472386900_CIT0049","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1093\/neuonc\/noab212","article-title":"TGF-beta promotes microtube formation in glioblastoma through thrombospondin 1","volume":"24","author":"Joseph","year":"2022","journal-title":"Neuro Oncol."},{"issue":"5","key":"2026012603472386900_CIT0050","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1016\/j.cell.2019.07.017","article-title":"Dipeptidase-1 is an adhesion receptor for neutrophil recruitment in lungs and liver","volume":"178","author":"Choudhury","year":"2019","journal-title":"Cell."},{"issue":"4","key":"2026012603472386900_CIT0051","first-page":"199","article-title":"DPEP1 mediates neutrophil and monocyte influx","volume":"18","author":"Wang","year":"2022","journal-title":"Nat Rev Nephrol."}],"container-title":["Neuro-Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/neuro-oncology\/advance-article-pdf\/doi\/10.1093\/neuonc\/noaf071\/63052221\/noaf071.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/neuro-oncology\/article-pdf\/27\/10\/2547\/63052221\/noaf071.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/neuro-oncology\/article-pdf\/27\/10\/2547\/63052221\/noaf071.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,26]],"date-time":"2026-01-26T08:47:48Z","timestamp":1769417268000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/neuro-oncology\/article\/27\/10\/2547\/8124753"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,4]]},"references-count":51,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2025,5,4]]},"published-print":{"date-parts":[[2025,10,1]]}},"URL":"https:\/\/doi.org\/10.1093\/neuonc\/noaf071","relation":{},"ISSN":["1522-8517","1523-5866"],"issn-type":[{"value":"1522-8517","type":"print"},{"value":"1523-5866","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,10]]},"published":{"date-parts":[[2025,5,4]]}}}